Clinical Trials Browser

INDUSTRY × Bone Marrow Neoplasms × Clear all

Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Thrombocytosis, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT03859427 2024-08-13

ARROW2

Phase 3 Completed

454 enrolled 24 charts

Plasma cell

Multiple Myeloma, Recurrence, Bone Marrow Neoplasms

NCT04709458 2022-05-03

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Phase 1 Unknown

10 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Bone Marrow Neoplasms, Primary Myelofibrosis

NCT01286077 2016-05-30

Velcade Consolidation Bone Study

Phase 2 Completed

106 enrolled 19 charts

Plasma cell

Multiple Myeloma, Bone Marrow Neoplasms

NCT00431340 2015-07-08

A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma

Phase 2 Terminated

4 enrolled

Plasma cell

Multiple Myeloma, Bone Marrow Neoplasms, Neoplasms, Plasma Cell

NCT00908232 2015-01-15

SEQUENTIAL

Phase 2 Completed

163 enrolled 11 charts

Plasma cell

Multiple Myeloma, Disease Progression, Bone Marrow Neoplasms

NCT00113893 2013-11-07

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Phase 2 Completed

62 enrolled

Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Bone Marrow Neoplasms

NCT00421213 2012-07-19

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Phase 2 Completed

50 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Bone Marrow Neoplasms, Hematologic Neoplasms

Clinical Trials

TREG108

ARROW2

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Velcade Consolidation Bone Study

A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma

SEQUENTIAL

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers